Responsible Artificial Intelligence in Radiation Oncology
Ching‐Ling Teng(Mount Sinai Health System), Dee Wu(University of Oklahoma Health Sciences Center), Preeti Patel(Indo Soviet Friendship College of Pharmacy), A.S. Bhullar(United States Food and Drug Administration), Richard D. Nawfel(Brigham and Women's Hospital), Michael Shang(Georgetown University), D. J. Jordon(University Hospitals of Cleveland), Peter R. Jermain(Georgetown University), R. Sean(The University of Texas Health Science Center at Houston)
International Journal of Radiation Oncology*Biology*Physics
September 27, 2024
Cited by 0
Related Papers
Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs
|Life|2023|209
A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer
|Drug Delivery and Translational Research|2024|141
Alternatives of Animal Models for Biomedical Research: a Comprehensive Review of Modern Approaches
|Stem Cell Reviews and Reports|2024|85
Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches
|European Journal of Medicinal Chemistry|2021|72
Furan and benzofuran derivatives as privileged scaffolds as anticancer agents: SAR and docking studies (2010 to till date)
|Journal of Molecular Structure|2023|60